Blog
RSS FeedPosted by Michael Wonder on 25 Sep 2018
Patients call for end to CF drug price row at key meeting
25 September 2018 - Representatives of NHS England and cystic fibrosis drug company Vertex are to meet on Thursday to ...
Posted by Michael Wonder on 17 Sep 2018
Targeted treatment for melanoma to be free on NHS
17 Septembre 2018 - Hundreds of patients with a type of aggressive skin cancer will be offered a targeted therapy ...
Posted by Michael Wonder on 14 Sep 2018
UK ‘less interesting’ to pharma because of Brexit – Roche CEO
14 September 2018 - The UK could be “less interesting” to pharma and life sciences firms after Brexit, the CEO ...
Posted by Michael Wonder on 13 Sep 2018
DoH moves to ensure equal access to cancer drugs in Northern Ireland
13 September 2018 - The Department of Health in Northern Ireland has unveiled plans to boost access to innovative new ...
Posted by Michael Wonder on 05 Sep 2018
Hand surgeon's career 'saved by gene-silencing drug'
5 September 2018 - Hand surgeon Carlos Heras-Palou said his career "would have been finished" in six months without the treatment. ...
Posted by Michael Wonder on 05 Sep 2018
Deal for NHS to offer exciting new child cancer therapy
5 September 2018 - A deal has been struck to let the NHS offer children an expensive new cancer therapy ...
Posted by Michael Wonder on 15 Aug 2018
‘I wish they approved this new leukaemia drug two years ago, then I wouldn’t have had to go through hell’
12 August 2018 - Chloe Pinder was just 23 when she was diagnosed with acute lymphoblastic leukaemia, a very rare type ...
Posted by Michael Wonder on 15 Aug 2018
'You have the medicine that can make me feel much better': boy, 8, pens letter asking drug company to lower prices
14 August 2018 - Watch eight-year-old Luis Walker, who has cystic fibrosis, read his letter to a pharmaceutical company urging ...
Posted by Michael Wonder on 18 Jul 2018
Vertex mulls over NHS England’s offer for CF drugs
18 July 2018 - Vertex Pharmaceuticals is considering a final offer from NHS England on funding for its cystic fibrosis ...
Posted by Michael Wonder on 09 Jul 2018
Vertex, NHS England no closer to Orkambi settlement
9 July 2018 - Vertex and NHS England remain locked in a battle over the provision of cystic fibrosis drug ...
Posted by Michael Wonder on 05 Jul 2018
Vertex calls NHS England ‘outrageous’ as Orkambi talks stall again
5 July 2018 - Public row about confidential pricing talks drags on. ...
Posted by Michael Wonder on 27 Jun 2018
Improving access to new treatments in rare diseases
21 June 2018 - Emily Crossley, co-founder and co-chief executive of Duchenne UK, tells us how a ground-breaking HERCULES project ...
Posted by Michael Wonder on 19 Jun 2018
Patients call for end to two-year row over cystic fibrosis drug funding
19 June 2018 - UK patients are stepping up efforts to resolve the “heartbreaking” row that is denying their families ...
Posted by Michael Wonder on 06 Jun 2018
Life-extending lung cancer drug will be more widely available on the NHS after NICE review
6 June 2018 - NICE says more people should be able to freely access pembrolizumab, known as Keytruda, after a new ...
Posted by Michael Wonder on 03 Jun 2018
Tesaro's ovarian cancer drug Zejula added to Cancer Drugs Fund
1 June 2018 - Tesaro's ovarian cancer drug Zejula (niraparib), the first PARP inhibitor shown to be effective in patients ...